Blood plasma derivatives are obtained from donated human blood plasma through various fractionating processes. Plasma derivatives are used in various therapeutic treatments including immunoglobulins, albumin, coagulation factors, and other plasma-derived medicinal products. The demand for plasma derivatives is rising rapidly due to the growing application of plasma therapy in the treatment of immunodeficiency disorders, hemophilia, alpha-1 antitrypsin deficiency, etc.
The global Blood Plasma Derivatives Market is estimated to be valued at US$ 44.33 Bn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising demand for plasma therapy is driving the growth of the blood plasma derivatives market substantially. Plasma therapy is gaining widespread adoption in the treatment of various chronic diseases. According to the World Federation of Hemophilia (WFH), hemophilia affects about 1 in 10,000 male births globally. Plasma-derived coagulation factors are extensively used in the management and treatment of hemophilia. Similarly, due to the increasing prevalence of immunodeficiency and autoimmune diseases, the demand for immunoglobulins from plasma is growing rapidly. Modernized plasma collection centers, increasing plasma donations, and growing patient awareness about plasma therapy are some of the key factors accelerating the demand for plasma-derived products globally during the forecast period.
Segment Analysis
The global blood plasma derivatives market is segmented on the basis of product type, application, end user, and region. The product type segment includes albumin, immunoglobulin, and other plasma based protein products. The albumin segment dominated the market with a share of over 40% in 2023 due to its medical applications such as maintaining blood volume and pressure along with treatment of bleeding disorders and burns. The application segment includes hypogammaglobulinemia, hemophilia, von Willebrand disease (VWD), and other applications. The immunoglobulin segment under application is expected to witness highest growth over the forecast period owing to increasing usage in treatment of autoimmune diseases like Guillain-Barré syndrome, CIDP, Myasthenia gravis, and others.
Key Takeaways
The global Blood Plasma Derivatives Market Size is expected to witness high growth over the forecast period. Growing prevalence of immunological and neurological disorders globally will continue boosting the demand for blood plasma derivatives. According to WHO estimates, approximately 1% of the global population is suffering from primary immunodeficiency (PID) and the number is rising steadily. This is expected to drive the immunoglobulin segment growth.
Regional analysis: North America dominated the global market in 2023 and is estimated to maintain its dominance over the forecast period. This can be attributed to increasing usage of plasma derivatives for management of bleeding disorders like hemophilia and autoimmune disorders like PID in the region. According to estimates, 2 out of every 1000 males are affected by hemophilia in the US. Asia Pacific is projected to witness fastest growth during the forecast period. Growing clinical research initiatives, rising healthcare expenditure, and increase in plasma collection centers are some key factors supporting the regional market growth.
Key players operating in the blood plasma derivatives market are Iron Mountain, ARC, Access, Shred-it, Restore plc, Cintas, Proshred, National Document Shredding Service, Shred Station, Red Dog Shred, Shred-X, Secured Document Shredding, Shred Works, Guardian Data Destruction, EndoShred, Mobile Shred, ShredQuick, ProShred Chicago, Shreds Unlimited.
Explore more Technology related article on this topic: https://www.ukwebwire.com/the-global-blood-plasma-derivatives-market-demand/
Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market.
Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world’s three giants.
In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%North America plays an important role in global bovine blood plasma derivatives market, especially United States, which has great influence on the development of bovine blood plasma derivatives.
In Europe market, Germany, UK, France and Italy are playing significant roles, especially Germany, which has absolute predominance in Europe market.
The Asia-Pacific will take an increasing significant part in global bovine blood plasma derivatives market, due to the strong demand from China, India and Southeast Asian countries.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-bovine-blood-plasma-derivatives-2019-2024-713According to this study, over the next five years the Bovine Blood Plasma Derivatives market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 2080 million by 2024, from US$ 1680 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Bovine Blood Plasma Derivatives business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Blood Plasma Derivatives market by product type, application, key manufacturers and key regions and countries.This study considers the Bovine Blood Plasma Derivatives value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Bovine SerumFBSBovine Serum AlbuminFibrinogenProtein IngredientOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.Scientific ResearchIndustrial ProductionFeedOthersThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.Thermo FisherGE HealthcareMerck (Sigma-Aldrich)Moregate BioTechGeminiAtlanta BiologicalsTissue Culture BiologicalsBovogenBiowestInternegociosRMBIOBiological IndustriesVWRCorningSeranaLanzhou MinhaiZhejiang Tianhang BiotechnologyExCell BioJin Yuan KangAmerican Protein CompanySonacIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
The global blood plasma derivatives market is growing mainly due to the increasing demand for plasma derived products.
According to a recent study report published by the Market Research Future, The global blood plasma derivatives market is booming and expected to gain prominence over the forecast period.
The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).Request Sample Copyhttps://www.marketresearchfuture.com/sample_request/1325Plasma is a fluid part of the blood that contains blood cells, and protein responsible for blood clotting.
The derivatives are then solvent detergent-treated or heat-treated to kill certain viruses.
Based on the prevalence rate, hemophilia and von willebrand disease (VWD) are the most common bleeding disorders in the Middle East and Africa.Other factors such as, rising incidence of hemophilia, huge funding for research & development, technological advancements, and rising approval from regulatory bodies are also fuelling the market growth.
According to the Centers for Disease Control and Prevention, it is found that Hemophilia A affects 1 in 5,000 male births i.e.
The Global Bovine Blood Plasma Derivatives Market research report offers accurate insights for the growth prospects of the Bovine Blood Plasma Derivatives market in the forecast years 2020-2027.
The report is an all-inclusive study of the Bovine Blood Plasma Derivatives market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic.
The global public health emergency has disrupted the lives of everyone across the globe.
It has also had a substantial impact on the Bovine Blood Plasma Derivatives industry as global supply chains have been disrupted, and the financial scenario is tight.
The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/3508Scope of the Market Report:The report offers a holistic overview of the Bovine Blood Plasma Derivatives industry that offers all the essential information.
Along with this, the report extensively studies the competitive landscape in the market and profiles the key players of the industry.The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies.
